Click Here To View
Latest Research Articles
Popular Research Articles
Highly Recommended Research Articles
Send a link to this page to your friends and colleagues.
Procter & Gamble Pharmaceuticals is sponsoring a new study on the safety and efficacy of INGAP-peptide.
The phase 2 study is interventional, randomized, double blinded, and placebo controlled.
Requirements for type 2s who wish to participate are:
Clinical Trials-National Institutes of Health, November 2003